(12) United States Patent (10) Patent No.: US 7,393,534 B2 Aylsworth Et Al
Total Page:16
File Type:pdf, Size:1020Kb
USOO7393534B2 (12) United States Patent (10) Patent No.: US 7,393,534 B2 Aylsworth et al. (45) Date of Patent: Jul. 1, 2008 (54) COMPOSITIONS AND METHODS FOR 5,821,047 A 10, 1998 Garrard et al. MMUNOTHERAPY OF CANCER AND 5,969,108 A 10/1999 McCafferty et al. NFECTIOUS DISEASES 6,001,363 A 12/1999 Tomley et al. (75) Inventors: Charles Aylsworth, Holt, MI (US); 6,008,342 A 12/1999 Binger et al. Siu-Cheong Ho, East Lansing, MI (US); 6,100,241 A 8, 2000 Kok et al. David Juckett, East Lansing, MI (US); 6,331415 B1 1 1/2001 Lind John W. Judge, Holt, MI (US); Igor V. 6,407,213 B1 6/2002 Carter et al. Zlatkin, Lansing, MI (US); Tatiana 6,451,984 B1 9/2002 Lillehoi et al. Zlatkin, Lansing, MI (US) 6,528,485 B1 3/2003 Veronese et al. (73) Assignee: Barros Research Institute, Holt, MI (US) (*) Notice: Subject to any disclaimer, the term of this FOREIGN PATENT DOCUMENTS patent is extended or adjusted under 35 EP 239.400 A2 9, 1987 U.S.C. 154(b) by 0 days. EP 519596 A1 12, 1992 (21) Appl. No.: 10/892,659 EP 592106 A1 4f1994 WO WO 86,05807 A1 6, 1987 (22) Filed: Jul. 15, 2004 WO WO 89.01.036 A1 2, 1989 WO WO90,02809 A1 3, 1990 (65) Prior Publication Data WO WO91f10737 A1 7, 1991 US 2005/O169935A1 Aug. 4, 2005 WO WO91f10741 A1 7, 1991 WO WO92/04461 3, 1992 Related U.S. Application Data WO WO92,06180 A1 4f1992 (60) Provisional application No. 60/487.336, filed on Jul. WO WO 91.01134 A1 10, 1992 15, 2003. (51) Int. Cl. A6 IK 38/00 (2006.01) (Continued) A6 IK 39/00 (2006.01) (52) U.S. Cl. ......................................... 424/185.1: 514/2 OTHER PUBLICATIONS (58) Field of Classification Search ................ 435/69.7; Aliberti et al. (2003), "Molecular mimicry of a CCR5 binding 424/185.1: 514/2 clomain in the microbial activation of dendritic cells”. Nature Immu See application file for complete search history. nology 4(5): 485-490. (56) References Cited (Continued) U.S. PATENT DOCUMENTS Primary Examiner Karen Cochrane Carlson 4,444,887 A 4, 1984 Hoffmann Assistant Examiner—Marsha Tsay 4,716,111 A 12/1987 Osband et al. (74) Attorney, Agent, or Firm Wolf, Greenfield & Sacks, 4,816,397 A 3, 1989 BOSS et al. P.C. 4,816,567 A 3/1989 Cabilly et al. 4,980,286 A 12/1990 Morgan et al. (57) ABSTRACT 5,122,464 A 6, 1992 Wilson et al. 5,223,409 A 6, 1993 Ladner et al. 5,225,539 A 7, 1993 Winter 5,403.484 A 4/1995 Ladner et al. The present invention provides compositions and methods for 5,427,908 A 6, 1995 Dower et al. the prevention and treatment of primary and metastatic neo 5,436,146 A 7, 1995 Shenk et al. plastic diseases and infectious diseases, for stimulating an 5,516,637 A 5/1996 Huang et al. immune response in a Subject, and for use as an alternative to 5,530,101 A 6/1996 Queen et al. interleukin-12 (IL-12) treatment. In particular, the present 5,565,332 A 10/1996 Hoogenboom et al. invention provides Apicomplexa-related proteins (ARPs) that 5,571,698 A 11/1996 Ladner et al. have immune stimulatory activity and thus have uses in the 5,580,717 A 12/1996 Dower et al. treatment and prevention of cancer and infectious diseases 5,585,089 A 12/1996 Queen et al. and in immune modulation. Compositions comprising an 5,658,727 A 8, 1997 Barbas et al. ARP are provided. Methods of use of an ARP for the preven 5,698,426 A 12, 1997 Huse tion and/or treatment of cancer and/or infectious diseases, for 5,733,743 A 3, 1998 Johnson et al. use as an alternative to interleukin-12 (IL-12) treatment, and 5,750,753 A 5, 1998 Kimae et al. for eliciting an immune response in a subject, are also pro 5,766,886 A 6, 1998 Studnicka et al. vided. 5,780,225 A 7/1998 Wigler et al. 5,792,644 A 8, 1998 Vermeulen et al. 5,807,715 A 9, 1998 Morrison et al. 13 Claims, 38 Drawing Sheets US 7,393,534 B2 Page 2 FOREIGN PATENT DOCUMENTS nucleoside Reverse Transcriptase Inhibitor of HIV Type I” AIDS Res. Hum. Retroviruses 1997, 13.9 pp. 789-796. WO WO92, 18619 A1 10, 1992 Burton et al., “Human Antibodies from Combinatorial Libraries” WO WO92/2O316 A2 11/1992 1994, Advances in Immunology 57:191-280. WO WO92,22324 A1 12, 1992 Cabilly et al. “Generation of antibody activity from immunoglobulin WO WO92,22635 A1 12, 1992 polypeptide chains produced in Escherichia coli Proc Natl AcadSci WO WO 93.14188 A1 7, 1993 USA. 81(11):3273-7 (1984). WO WO93/15199 A1 8, 1993 Caldas et al., “Design and sythesis of germline-based hemi-human WO WO93, 1520O A1 8, 1993 ized single-chain Fv against the CD18surface antigen” Protein Eng. WO WO93f2O221 A1 10, 1993 13(5):353-60 (2000). WO WO94,08598 A1 4f1994 Campos et al., “Activation of Toll-Like Receptor-2 by WO WO 94,12649 A2 6, 1994 Glycosylphosphatidylinositol Anchors from a Protrozoan Parasite s WO WO93, 17105 A1 12, 1994 The J. Immunol. 2001, 167:416–423. WO WO95/15982 A2 6, 1995 Carpenter, et al., “Antiretroviral Therapy for HIV infection in 1998” WO WO95/2O401 A1 8, 1995 JAMA 280(1): 78-86 (1998). WO WO96,33735 A1 10, 1996 Chomczynsky, P., and N. Sacchi. “Single-Step Method RNA Isola WO WO 96/34096 A1 10, 1996 tion by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extrac WO WO 97.13844 A1 4f1997 tion 1987. Anal. Biochem. 162:156-159. WO WO 98.24893 A2 6, 1998 Chothia et al., 1998, "Structural Determinants in the Sequences of WO WO 98,46645 A2 10, 1998 Immunoglobulin Variable Domain” J. Mol. Biol. 278: 457-479. WO WO 93,11236 A1 3, 1999 Chou, P. and Fasman, G., “Prediction of Protein Conformation” WO WO 98.16654 A1 6, 1999 1974, Biochemistry vol. 13: No. 2 222. WO WO91,09967 A1 7, 1999 Cline, "Perspectives For Gene Therapy. Inserting New Genetic Infor WO WO92fO1047 A1 10, 1999 mation Into Mammalian Cells By Physical Techniques And Viral WO WO98,50433 A2 5, 2001 Vectors' 1985, Pharmac. Ther. 29:69-92. WO WOO1,77137 A1 10, 2001 Clowes et al., “Long-Term Biological Response of Injured Rat WO WO 2004/020630 3, 2004 Carotid Artery Seeded with Smooth Muscle Cells Expressing Retrovirally Introduced Human Genes' 1994, J. Clin. Invest. 93:644 OTHER PUBLICATIONS 651. Cockettet al., “High Level Expression Of TissueIbnhibitor OfMetal Allen & Fetterer, (2002), “Recent Advances in Biology and loproteinases. In Chinese Hamster Ovary Cells Using Glutamine Immunobiology of Eimeria Species and in Diagnosis and Control of Synthetase Gene Amplification”. Jul. 1990, Bio/Technology 8: pp. Infection with These Occidian Parasites of Poultry.” Clin. Microbiol. 662-667. Rev. 15:58-65. Cotten et al., 1993, "Receptor-Mediated Transport of DNA into Almeida and Gazzinelli, "Proinflammatory activity of Eukaryotic Cells” Meth. Enzymol. 217:618-644. glycosylphosphatidylinositol anchors derived from Trypanosoma Colberre-Garapin et al., “A New Dominant Hybrid Selective Marker cruzi: structural and functional analyses' J Leukoc Biol. 70(4):467 for Higher Eukaryotic Cells”, 1981, J. Mol. Biol. 150: 1-14. 77 (2001). Couto et al., Designing Human Consensus Antibodies with Minimal Altschulet al., “Gapped BLAST and PSI-BLAST: a new generation of Positional Templates' Cancer Res. 55 (23 Supp):5973s-5977s (Dec. protein database search programs”Nucleic Acids Res. 25(17):3389 1, 1995). 3402, 1997. Couto et al., “Anti-BA46 Monoclonal Antibody Mc3. Humanization Ames et al., “Conversion of murine Fabs isolated from a Using a Novel Positional Concensus and in Vivo and in Vitro Char combinatoria phage display library to full length immunoglobulins' acterization” Cancer Res. 55(8): 1717-22 (Apr. 15, 1995). 1995, J. Immunol. Methods 184:177-186. Crouse et al., “Expression and Amplification of Engineered Mouse Ausubel et al., (eds.), “Informatics For Molecular Biologists' Cur Dihydrofolate Reductase Minigenes” (Feb. 1983), Mol. Cell. Biol. rent Protocols in Molecular Biology, Ch. 19 John Wiley & Sons, NY vol. 3, No. 2, pp. 257-266. (2002). Davies etal “Isolation of DNA from Plants” (Methods in Molecular Baca et al., “Antibody Humanization Using Monovalent Phage Dis Biology vol. 28: Protocols for nucleic acid analysis by non-radioac play” J. Biol. Chem. 272(16):10678-84 (1997). tive probes, Isaac, P.G. (ed) pp. 9-15, Humana Press Inc., TotowaN.J. Bebbington and Hentschel. The use of vectors based on gene ampli USA (date?)). fication for the expression of cloned genes in mammalian cellsvol. 3. Dracopoli et al. (eds), Chapters 12 and 13, Current Protocols in (Academic Press, New York, 1987) pp. 163-189. Human Genetics, John Wiley & Sons, NY (1994). Better et al., “Escherichia coli Secretion of an Active Chimeric Anti Engstrom, A., “The Arrangement Of The Protein Molecules In body Fragment” 1988, Science 240: 1041-1043. Nuclear-Polyhedrosis Inclusions' 1974, Biochem. Exp. Biol. 11:7- Beverley, Cell, “Hijacking the Cell: Parasites in the Driver's Seat” 13. 1996 87: 787-789. Faber et al., “Eimeria Infections in Cows in the Periparturient Phase, Bitter et al., “Expression and Secretion Vectors For Yeast, 1987. And Their Calves. Oocyst Excretion and Levels of Specific Serum and Methods in Enzymol. 153:516-544. Colostrum Antibodies”. (2002), Vet.